Amit Dutt, Ph.D.

Affiliations: 
Department of Genetics University of Delhi South Campus 
Area:
Cancer genomics, Cancer genetics, Human genetics, Cancer
Website:
https://www.actrec.gov.in/pi-webpages/AmitDutt/dutt_index.html
Google:
"Amit Dutt"
Bio:

(Show more)

Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Desai S, Ahmad S, Bawaskar B, et al. (2024) Singleton mutations in large-scale cancer genome studies: uncovering the tail of cancer genome. Nar Cancer. 6: zcae010
Chougule A, Chandrani P, Noronha V, et al. (2023) Real-World Evidence of EGFR Targeted Therapy in NSCLC- A Brief Report of Decade Long Single Center Experience. Jto Clinical and Research Reports. 4: 100566
Joshi A, Butle A, Hait S, et al. (2022) Osimertinib for lung cancer cells harboring low-frequency EGFR T790M mutation. Translational Oncology. 22: 101461
Butle A, Joshi A, Noronha V, et al. (2021) Weekly osimertinib dosing prevents EGFR mutant tumor cells destined to home mouse lungs. Translational Oncology. 14: 101111
Togar T, Desai S, Mishra R, et al. (2020) Identifying cancer driver genes from functional genomics screens. Swiss Medical Weekly. 150: w20195
Gupta S, Chaubal R, Gardi N, et al. (2020) Abstract P3-05-01: Molecular effects of surgical resection on primary breast tumor Cancer Research. 80
Sikder S, Kumari S, Kumar M, et al. (2019) Chromatin protein PC4 is downregulated in breast cancer to promote disease progression: Implications of miR-29a. Oncotarget. 10: 6855-6869
Arora R, Rekhi B, Chandrani P, et al. (2019) Merkel cell polyomavirus is implicated in a subset of Merkel cell carcinomas, in the Indian subcontinent. Microbial Pathogenesis. 103778
Noronha V, Patil VM, Joshi A, et al. (2019) Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in -Mutated Lung Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901154
Singh S, Kumar M, Kumar S, et al. (2019) The cancer-associated, gain-of-function TP53 variant P152Lp53 activates multiple signaling pathways implicated in tumorigenesis. The Journal of Biological Chemistry
See more...